Publications

Export 30 results:
Auteur Title [ Type(Desc)] Année
Filtres: Mot-clé is Treatment Outcome  [Enlever les filtres]
Journal Article
Bedford R, Pickles A, Gliga T, Elsabbagh M, Charman T, Johnson MH.  2014.  Additive effects of social and non-social attention during infancy relate to later autism spectrum disorder.. Dev Sci. 17(4):612-20.
Berlim M, Van den Eynde F, Tovar-Perdomo S, Chachamovich E, Zangen A, Turecki G.  2014.  Augmenting antidepressants with deep transcranial magnetic stimulation (DTMS) in treatment-resistant major depression.. World J Biol Psychiatry. 15(7):570-8.
Gauthier S, Proaño JVoltaire, Jia J, Froelich L, Vester JChristophe, Doppler E.  2015.  Cerebrolysin in mild-to-moderate Alzheimer's disease: a meta-analysis of randomized controlled clinical trials.. Dement Geriatr Cogn Disord. 39(5-6):332-47.
Guimond S, Lepage M.  2016.  Cognitive training of self-initiation of semantic encoding strategies in schizophrenia: A pilot study.. Neuropsychol Rehabil. 26(3):464-79.
Desan PH, Weinstein AJ, Michalak EE, Tam EM, Meesters Y, Ruiter MJ, Horn E, Telner J, Iskandar H, Boivin DB et al..  2007.  A controlled trial of the Litebook light-emitting diode (LED) light therapy device for treatment of Seasonal Affective Disorder (SAD).. BMC Psychiatry. 7:38.
Kedzior KKarolina, Gellersen HMarie, Brachetti AKatharina, Berlim M.  2015.  Deep transcranial magnetic stimulation (DTMS) in the treatment of major depression: An exploratory systematic review and meta-analysis.. J Affect Disord. 187:73-83.
Lam RW, Milev R, Rotzinger S, Andreazza AC, Blier P, Brenner C, Daskalakis ZJ, Dharsee M, Downar J, Evans KR et al..  2016.  Discovering biomarkers for antidepressant response: protocol from the Canadian biomarker integration network in depression (CAN-BIND) and clinical characteristics of the first patient cohort.. BMC Psychiatry. 16:105.
Santisteban JA, Stein MA, Bergmame L, Gruber R.  2014.  Effect of extended-release dexmethylphenidate and mixed amphetamine salts on sleep: a double-blind, randomized, crossover study in youth with attention-deficit hyperactivity disorder.. CNS Drugs. 28(9):825-33.
McGirr A, Van den Eynde F, Tovar-Perdomo S, Fleck MPA, Berlim M.  2015.  Effectiveness and acceptability of accelerated repetitive transcranial magnetic stimulation (rTMS) for treatment-resistant major depressive disorder: an open label trial.. J Affect Disord. 173:216-20.
Berlim M, McGirr A, Van den Eynde F, Fleck MPA, Giacobbe P.  2014.  Effectiveness and acceptability of deep brain stimulation (DBS) of the subgenual cingulate cortex for treatment-resistant depression: a systematic review and exploratory meta-analysis.. J Affect Disord. 159:31-8.
Urbanoski K, Veldhuizen S, Krausz M, Schutz C, Somers JM, Kirst M, MJ Fleury, Stergiopoulos V, Patterson M, Strehlau V et al..  2018.  Effects of comorbid substance use disorders on outcomes in a Housing First intervention for homeless people with mental illness.. Addiction. 113(1):137-145.
Gauthier S, Rountree S, Finn B, LaPlante B, Weber E, Oltersdorf T.  2015.  Effects of the Acetylcholine Release Agent ST101 with Donepezil in Alzheimer's Disease: A Randomized Phase 2 Study.. J Alzheimers Dis. 48(2):473-81.
Florian H, Meier A, Gauthier S, Lipschitz S, Lin Y, Tang Q, Othman AA, Robieson WZ, Gault LM.  2016.  Efficacy and Safety of ABT-126 in Subjects with Mild-to-Moderate Alzheimer's Disease on Stable Doses of Acetylcholinesterase Inhibitors: A Randomized, Double-Blind, Placebo-Controlled Study.. J Alzheimers Dis. 51(4):1237-47.
Simoneau H, Kamgang E, Tremblay J, Bertrand K, Brochu S, MJ Fleury.  2018.  Efficacy of extensive intervention models for substance use disorders: A systematic review.. Drug Alcohol Rev. 37 Suppl 1:S246-S262.
Hou L, Heilbronner U, Degenhardt F, Adli M, Akiyama K, Akula N, Ardau R, Arias B, Backlund L, Banzato CEM et al..  2016.  Genetic variants associated with response to lithium treatment in bipolar disorder: a genome-wide association study.. Lancet. 387(10023):1085-93.
Thaler L, Wilson S, Coelho JS, Antunes JMazanek, Israel M, Steiger H.  2014.  Mandating weekly weight gain in a day treatment program for eating disorders.. Int J Eat Disord. 47(5):500-6.
Godlewska BR, Near J, Cowen PJ.  2015.  Neurochemistry of major depression: a study using magnetic resonance spectroscopy.. Psychopharmacology (Berl). 232(3):501-7.
Behdinan T, Foussias G, Wheeler AL, Stefanik L, Felsky D, Remington G, Rajji TK, M Chakravarty M, Voineskos AN.  2015.  Neuroimaging predictors of functional outcomes in schizophrenia at baseline and 6-month follow-up.. Schizophr Res. 169(1-3):69-75.
Hunsberger JG, Chibane FL, Elkahloun AG, Henderson R, Singh R, Lawson J, Cruceanu C, Nagarajan V, Turecki G, Squassina A et al..  2015.  Novel integrative genomic tool for interrogating lithium response in bipolar disorder.. Transl Psychiatry. 5:e504.
Sauchelli S, Jiménez-Murcia S, Sánchez I, Riesco N, Custal N, Fernández-García JC, Garrido-Sánchez L, Tinahones FJ, Steiger H, Israel M et al..  2016.  Orexin and sleep quality in anorexia nervosa: Clinical relevance and influence on treatment outcome.. Psychoneuroendocrinology. 65:102-8.
Blackhall F, Kim D-W, Besse B, Nokihara H, Han J-Y, Wilner KD, Reisman A, Iyer SN, Hirsh V, Shaw AT.  2014.  Patient-reported outcomes and quality of life in PROFILE 1007: a randomized trial of crizotinib compared with chemotherapy in previously treated patients with ALK-positive advanced non-small-cell lung cancer.. J Thorac Oncol. 9(11):1625-33.
McGirr A, Van den Eynde F, Chachamovich E, Fleck MPA, Berlim M.  2014.  Personality dimensions and deep repetitive transcranial magnetic stimulation (DTMS) for treatment-resistant depression: a pilot trial on five-factor prediction of antidepressant response.. Neurosci Lett. 563:144-8.
Mamdani F, Berlim M, Beaulieu M-M, Turecki G.  2014.  Pharmacogenomic predictors of citalopram treatment outcome in major depressive disorder.. World J Biol Psychiatry. 15(2):135-44.
Berlim M, Van den Eynde F.  2014.  Repetitive transcranial magnetic stimulation over the dorsolateral prefrontal cortex for treating posttraumatic stress disorder: an exploratory meta-analysis of randomized, double-blind and sham-controlled trials.. Can J Psychiatry. 59(9):487-96.
Berlim M, van den Eynde F, Tovar-Perdomo S, Daskalakis ZJ.  2014.  Response, remission and drop-out rates following high-frequency repetitive transcranial magnetic stimulation (rTMS) for treating major depression: a systematic review and meta-analysis of randomized, double-blind and sham-controlled trials.. Psychol Med. 44(2):225-39.

Pages